Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiasp versus NovoRapid in pregnant women with type 1 or type 2 diabetes
2018-004680-31Phase 3Completed
- Sponsor
- Lene Ringholm
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) comparing Fiasp arm with NovoRapid arm (2 arms). Primary endpoint: Offspring birth weight adjusted for gestational age and gender. Started Apr 2019; status: completed.
02
Drugs
human insulininsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2018-004680-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004680-31.